Denali Therapeutics Inc.DNLINASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank50
3Y CAGR-7.8%
5Y CAGR-6.5%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-7.8%/yr
vs +21.9%/yr prior
5Y CAGR
-6.5%/yr
Consistent
Acceleration
-29.7pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.14B | -16.7% |
| 2024 | $1.37B | +19.1% |
| 2023 | $1.15B | -21.0% |
| 2022 | $1.46B | +4.0% |
| 2021 | $1.40B | -12.5% |
| 2020 | $1.60B | +190.0% |
| 2019 | $553.23M | -16.4% |
| 2018 | $661.98M | +36.0% |
| 2017 | $486.72M | +79.6% |
| 2016 | $271.07M | - |